Position in CYTK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,976,408
New position
Shares Held
23,200
first reported quarter
Ownership
0.017%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#221
of 477 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Homestead Advisers Corp holds $101,557,390 across 6 Biotechnology names. CYTK ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
1,657,242 | $92,921,558 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
6,500 | $2,176,135 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
5,500 | $2,044,185 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
34,400 | $1,999,672 | |
| 5 | CYTK |
Cytokinetics Inc
This page
|
23,200 | $1,976,408 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
5,900 | $439,432 |
All Filings in CYTK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,976,408 | 23,200 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||